Sequoia and Greylock co led the Series B round for the immigrant focused fintech firm.
"The latest fundraising allows us to accelerate our mission of building a truly global financial ecosystem for diaspora communities. We’re just getting started our users deserve modern financial infrastructure that works across borders."
The funding round was supported by BGF, Parkwalk Advisors, DBW, and BBI to drive clinical and product development.
"This investment is a strong endorsement of our team, technology, and vision. The early clinical data from our temporary device has given us real momentum, and with this funding, we’re excited to advance our permanent pacing platform, an innovation that could redefine how heart failure is treated."
The seed round was co-led by AlbionVC and Spark Capital to support product development.
"AI gives us the opportunity to transform not only how developers create games, but also how players experience them. While many companies are using AI to optimise existing workflows, we're focused on enabling something fundamentally new – emergent, interactive animation that reacts in real time. Our aim is to evolve the animation paradigm towards emergent physical behaviors, opening up new creative possibilities for developers and dynamic experiences for players."
The funding round was backed by Guinness Ventures, Conduit Fund, Octopus Ventures, and Macmillan Cancer Support, exceeding the company's initial €2m target.
"Supporting businesses developing scalable, meaningful impact in healthcare is a priority for us,"
British Design Fund and Imperial College Enterprise Fund back the healthcare startup to launch its first product.
"The idea for our product came from years spent on hospital wards during my career as a design researcher in healthcare. I noticed that gravity infusions were often inaccurate, and fluid balance management was generally poor. This inspired me to dedicate my career to designing solutions that could make a real difference in patient care."